Researchers Develop Worlds First Plastic Antibodies

Article

UC Irvine researchers have developed the first “plastic antibodies” successfully employed in live organisms – stopping the spread of bee venom through the bloodstream of mice.

Tiny polymeric particles – just 1/50,000th the width of a human hair – were designed to match and encase melittin, a peptide in bee venom that causes cells to rupture, releasing their contents. Large quantities of melittin can lead to organ failure and death.

The polymer nanoparticles were prepared by “molecular imprinting” a technique similar to plaster casting: UCI chemistry professor Kenneth Shea and project scientist Yu Hoshino linked melittin with small molecules called monomers, solidifying the two into a network of long polymer chains. After the plastic hardened, they removed the melittin, leaving nanoparticles with minuscule melittin-shaped holes.

When injected into mice given high doses of melittin, these precisely imprinted nanoparticles enveloped the matching melittin molecules, “capturing” them before they could disperse and wreak havoc – greatly reducing deaths among the rodents.

“Never before have synthetic antibodies been shown to effectively function in the bloodstream of living animals,” Shea says. “This technique could be utilized to make plastic nanoparticles designed to fight more lethal toxins and pathogens.”

Takashi Kodama of Stanford University and Hiroyuki Koide, Takeo Urakami, Hiroaki Kanazawa and Naoto Oku of Japan’s University of Shizuoka also contributed to the study, published recently in the Journal of the American Chemical Society.

Unlike natural antibodies produced by live organisms and harvested for medical use, synthetic antibodies can be created in laboratories at a lower cost and have a longer shelf life.

“The bloodstream includes a sea of competing molecules – such as proteins, peptides and cells – and presents considerable challenges for the design of nanoparticles,” Shea says. “The success of this experiment demonstrates that these challenges can be overcome.”

Related Videos
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Related Content